Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial

Published:2021-11 Issue:11 Volume:3 Page:e767-e777
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Tascilar Koray,Hagen Melanie,Kleyer Arnd,Simon David,Reiser Michaela,Hueber Axel J,Manger Bernhard,Englbrecht Matthias,Finzel Stephanie,Tony Hans-Peter,Schuch Florian,Kleinert Stefan,Wendler Joerg,Ronneberger Monika,Figueiredo Camille P,Cobra Jayme F,Feuchtenberger Martin,Fleck Martin,Manger Karin,Ochs Wolfgang,Schmitt-Haendle Matthias,Lorenz Hanns-Martin,Nuesslein Hubert,Alten Rieke,Kruger Klaus,Henes Joerg,Schett Georg,Rech Juergen

Funder

IMI

ERC

DFG

BMBF Berlin

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference31 articles.

1. The pathogenesis of rheumatoid arthritis;McInnes;N Engl J Med,2011

2. Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010;Aga;Ann Rheum Dis,2015

3. [Clinical remission in rheumatoid arthritis. Data from the early arthritis cohort study CAPEA];Albrecht;Z Rheumatol,2016

4. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort;Combe;J Rheumatol,2013

5. Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study;Vittecoq;BMJ Open,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial;The Lancet Rheumatology;2024-05

2. 2023 Management Recommendations of Bangladesh Rheumatology Society on Pharmacological Treatment of Rheumatoid Arthritis With Synthetic and Biologic Disease-Modifying Drugs;Cureus;2024-04-30

3. Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission;Nature Communications;2024-02-05

4. A real-world 2-year prospective study of medication tapering in patients with well-controlled rheumatoid arthritis within the rheumatoid arthritis medication tapering (RHEUMTAP) cohort;Rheumatology;2023-10-01

5. Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial;Rheumatology International;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3